| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | uridine | 0.5473 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.5492 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.5841 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.5860 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6058 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6089 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6315 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6437 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6482 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6515 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6580 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6582 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6754 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6841 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.6930 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7031 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7164 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7373 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7496 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7559 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7673 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7683 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7744 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7837 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7881 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.7994 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8111 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8145 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8166 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8177 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8332 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8424 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8442 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8456 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8474 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8476 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8497 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8539 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8545 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8576 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8578 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8588 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8620 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8631 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8663 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8842 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8873 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.8974 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9008 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9075 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9083 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9128 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9149 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9192 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9221 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9229 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9268 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9312 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9321 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9323 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9398 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9419 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9454 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9521 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9531 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9537 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9545 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9559 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9587 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9590 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9595 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9612 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9619 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9621 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9633 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9643 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9649 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9654 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9654 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9698 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9740 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9755 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9763 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9790 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9795 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9798 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9856 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9857 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9879 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9949 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9950 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 0.9955 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0000 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0003 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0020 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0045 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0054 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0131 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0140 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0154 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0175 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0178 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0180 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0189 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0216 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0238 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0255 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0340 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0346 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0352 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0353 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0362 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0373 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0376 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0440 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0441 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0459 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0468 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0469 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0470 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0472 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0547 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0585 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0599 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0646 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0647 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0673 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0701 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0716 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0739 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0744 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0744 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0764 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0766 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0869 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0883 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0912 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0913 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0923 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0926 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0933 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0941 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0956 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0957 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0968 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.0986 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1076 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1096 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1106 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1139 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1165 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1167 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1191 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1213 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1233 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1379 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1444 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1491 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1543 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1603 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1728 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1744 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1792 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1859 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1926 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1947 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.1991 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2077 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2113 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2160 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2204 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2356 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2426 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2448 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2453 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2493 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2652 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2775 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2783 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2808 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.2988 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.3012 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.3143 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.3551 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.3986 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | uridine | 1.4077 | scaled units | High-Dose | +71HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|